Integrated analysis of abnormal metabolic homeostasis for decoding tumor microenvironment
Qiang Yang,Ying Cai,Shi Qiu,Aihua Zhang
DOI: https://doi.org/10.3389/fmolb.2024.1443642
IF: 6.113
2024-10-16
Frontiers in Molecular Biosciences
Abstract:In 2023 and 2024, Nature published a series of crucial roles of metabolic abnormalities in tumor occurrence, development, and treatment, based on which prognosis and treatment were performed. These studies show that abnormal metabolism of tumor cells is a key factor in malignant proliferation and immune escape, and targeting and regulating abnormal metabolism of tumor cells may become a new strategy for tumor treatment. Serine metabolism, as a key factor driving the occurrence and development of tumors, can provide material and energy basis for the proliferation of tumor cells, reduce oxidative stress and promote the survival of tumor cells. (Papalazarou et al., 2023) Some researchers have focused on transmembrane peptides in the serine metabolism pathway in liver cancer cells, and found that transmembrane peptides can competitively inhibit the rate-limiting enzyme of serine synthesis reaction, reduce its enzyme activity, inhibit serine metabolism, and promote the accumulation of intracellular ROS, thereby showing an inhibitory effect on liver cancer cells. Therefore, a new way of treating liver cancer is found from abnormal serine metabolism of liver cancer cells. (Wang et al., 2023) Some researchers have focused on the regulation and metabolism of protein translation in glioblastoma.They found that threonine can catalyze the formation of t6A modification by YRDC, which triggers proteome reprogramming, thereby promoting mitotic gene expression. In brief, limiting threonine intake may be a key entry point to limit glioblastoma growth. (Wu et al., 2023).Metabolomics, transcriptomics, and comprehensive analysis methods have been widely used to identify potential metabolic biomarkers in tumor cells, focusing on upstream and downstream macromolecular metabolites such as proteins, nucleotides, and lipids. Many metabolic pathways in tumor cells, including fatty acid metabolism, cholesterol metabolism, glutamine metabolism, serine metabolism, carbon unit metabolism, choline metabolism, were reprogrammed. Gong et al. found that the development and activation of regulatory T cells in nasopharyngeal carcinoma cells is regulated by cell-to-cell interactions mediated by oxidative phosphorylation driven by lipid signaling networks. In summary, mitochondrial integrity, cholesterol accumulation, and fatty acid metabolism in tumor cells work together to improve Tregs function. (Gong et al., 2023).These studies confirmed that tumor cells can induce immune escape by secreting small molecule metabolites and releasing a variety of immunosuppressive factors to form an immunosuppressive microenvironment. For example, pancreatic cancer-associated fibroblasts can enhance the environmental adaptability of cancer cells by secreting acetic acid acting on the ACSS2-SP1-SAT1 axis. (Murthy et al., 2024) Tumor cell can secrete related metabolites, which act on the tumor microenvironment and affect host function. In a new study, Wang G and other researchers found that tumor cells can release soluble factors into the blood, disrupt the body's homeostasis, and produce pathological changes in the liver, making it enter an inflammatory state, inducing the secretion of proinflammatory cytokines such as TNF and IL-1α, inhibiting the related lipid metabolic pathways, leading to fat accumulation and liver function damage. This study demonstrates the critical role of multi-tissue cooperation in cancer and helps unravel the mechanism of tumor cell survival. (Wang et al., 2023). It is worth noting that the recovery of abnormal metabolic state by regulating the metabolites related to tumor cells can be used as an important strategy to regulate the efficacy of tumor therapy. Lipid metabolism disorder, as a key factor causing the elevation of aerobic glycolysis levels and the disruption of the tricarboxylic acid cycle in tumor cells, is involved in the synthesis of fatty acids and cholesterol compounds in tumor cells. Studies have found that found that CD40 drives the proinflammatory effect and anti-tumor polarization in macrophages by regulating the metabolism of fatty acid oxidation and glutamine. Uncovering new dimensions of immune metabolic regulation and strategies that can restore effective anticancer immune responses and help cancer patients reprogram depleted T cells (Liu et al., 2023).Abnormal lipid metabolism in tumor cells is mainly manifested as increased lipid uptake, fatty acid oxidation and storage, etc. These metabolic changes will favor malignant tumor proliferation and tumor microenvironment remodeling.Due to mutations in genes related to tumors and the microenvironment surrounding them, the metabolic processes in tumor cells undergo modifications to support the rapid growth of the cells. The metabolism of tumor cells is subject to reprogramming of their metabolic pathways, and changes in metabolic phenotypes occur as the tumor develops: from nutrient uptake during the early stages of -Abstract Truncated-
biochemistry & molecular biology